Recent research provides evidence that a high plasma level of fibroblast growth factor-23 (FGF)-23 is a hallmark of cardiac damage resulting in deleterious remodelling and the induction of cardiac hypertrophy. Here, FGF23 is linked to cardiac hypertrophy.